Advanced search
Publication Cover
Journal of Biological Dynamics Volume 16, 2022 - Issue 1
Submit an article Journal homepage
2,143
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Comparison of classical tumour growth models for patient derived and cell-line derived xenografts using the nonlinear mixed-effects framework

Dimitrios Voulgarelisa DMPK Oncology R&D, AstraZeneca, Cambridge, UK;b Early Computational Oncology, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK;c AstraZeneca Postdoc Programme, Cambridge, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8857-7899View further author information
ORCID Icon,
Krishna C. Bulusub Early Computational Oncology, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UKORCID Iconhttps://orcid.org/0000-0002-5092-6640View further author information
ORCID Icon &
James W. T. Yatesa DMPK Oncology R&D, AstraZeneca, Cambridge, UKView further author information
Pages 160-185 | Received 27 Jul 2021, Accepted 11 Mar 2022, Published online: 11 Apr 2022

References

  • H. Akaike, On entropy maximization principle, Appl. Stat. (1977), pp. 27–41.
  • J. Almquist, J. Leander, and M. Jirstrand, Using sensitivity equations for computing gradients of the foce and focei approximations to the population likelihood, J. Pharmacokinet. Pharmacodyn. 42 (2015), pp. 191–209.
  • Ž. Bajzer, S. Vuk-Pavlović, and M. Huzak, Mathematical Modeling of Tumor Growth Kinetics, A Survey of Models for Tumor-Immune System Dynamics, Springer, 1997, pp. 89–133.
  • S. Benzekry, C. Lamont, A. Beheshti, A. Tracz, J.M. Ebos, L. Hlatky, and P. Hahnfeldt, Classical mathematical models for description and prediction of experimental tumor growth, PLoS. Comput. Biol. 10 (2014), p. e1003800.
  • M. Bissery, P. Vrignaud, F. Lavelle, and G. Chabot, Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (cpt-11) in mice., Anticancer. Drugs. 7 (1996), pp. 437–460.
  • H. Brown and R. Prescott, Applied Mixed Models in Medicine, John Wiley & Sons, Edinburgh, 2014.
  • A.C. Burton, Rate of growth of solid tumours as a problem of diffusion, Growth 30 (1966), pp. 157–176.
  • A.D. Conger and M.C. Ziskin, Growth of mammalian multicellular tumor spheroids, Cancer Res. 43 (1983), pp. 556–560.
  • B. Efron, Estimating the error rate of a prediction rule: Improvement on cross-validation, J. Amer. Statist. Assoc. 78 (1983), pp. 316–331.
  • N.D. Evans, R.J. Dimelow, and J.W. Yates, Modelling of tumour growth and cytotoxic effect of docetaxel in xenografts, Comput. Methods Programs. Biomed. 114 (2014), pp. e3–e13.
  • M. Fidler, J.J. Wilkins, R. Hooijmaijers, T.M. Post, R. Schoemaker, M.N. Trame, Y. Xiong, and W.Wang, Nonlinear mixed-effects model development and simulation using nlmixr and related r open source packages, CPT: pharmacometrics Syst. Pharmacol. 8 (2019), pp. 621–633.
  • H. Gao, J.M. Korn, S. Ferretti, J.E. Monahan, Y. Wang, M. Singh, C. Zhang, C. Schnell, G. Yang, Y.Zhang, and O.A. Balbin, High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response, Nat. Med. 21 (2015), pp. 1318–1325.
  • J.W. Hogan and N.M. Laird, Model-based approaches to analysing incomplete longitudinal and failure time data, Stat. Med. 16 (1997), pp. 259–272.
  • N.L. Jumbe, Y. Xin, D.D. Leipold, L. Crocker, D. Dugger, E. Mai, M.X. Sliwkowski, P.J. Fielder, and J. Tibbitts, Modeling the efficacy of trastuzumab-dm1, an antibody drug conjugate, in mice, J. Pharmacokinet. Pharmacodyn. 37 (2010), pp. 221–242.
  • J. Jung, H.S. Seol, and S. Chang, The generation and application of patient-derived xenograft model for cancer research, Cancer Res. Treat.: Official J. Korean Cancer Assoc. 50 (2018), pp. 1–10.
  • M. Marušić, Ž. Bajzer, J. Freyer, and S. Vuk-Pavlović, Analysis of growth of multicellular tumour spheroids by mathematical models, Cell. Prolif. 27 (1994), pp. 73–94.
  • M. Marušić, S. Vuk-Pavlovic, and J.P. Freyer, Tumor growth in vivo and as multicellular spheroids compared by mathematical models, Bull. Math. Biol. 56 (1994), pp. 617–631.
  • W.V. Mayneord, On a law of growth of Jensen's rat sarcoma, Am. J. Cancer. 16 (1932), pp. 841–846.
  • S. Michelson, A. Glicksman, and J. Leith, Growth in solid heterogeneous human colon adenocarcinomas: Comparison of simple logistical models, Cell. Prolif. 20 (1987), pp. 343–355.
  • D. Mould and R.N. Upton, Basic concepts in population modeling, simulation, and model-based drug development part 2: Introduction to pharmacokinetic modeling methods, CPT: Pharmacometrics Syst. Pharmacol. 2 (2013), pp. 1–14.
  • L. Norton and R. Simon, Growth curve of an experimental solid tumor following radiotherapy, J. Natl. Cancer Inst. 58 (1977), pp. 1735–1741.
  • Z.P. Parra-Guillen, V. Mangas-Sanjuan, M. Garcia-Cremades, I.F. Troconiz, G. Mo, C. Pitou, P.W.Iversen, and J.E. Wallin, Systematic modeling and design evaluation of unperturbed tumor dynamics in xenografts, J. Pharmacol. Exp. Ther. 366 (2018), pp. 96–104.
  • M. Simeoni, P. Magni, C. Cammia, G. De Nicolao, V. Croci, E. Pesenti, M. Germani, I. Poggesi, and M. Rocchetti, Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents, Cancer Res. 64 (2004), pp. 1094–1101.
  • V.G. Vaidya and F.J. Alexandro Jr, Evaluation of some mathematical models for tumor growth, Int. J. Biomed. Comput. 13 (1982), pp. 19–35.
  • P.F. Verhulst, Notice sur la loi que la population suit dans son accroissement, Corresp. Math. Phys.10 (1838), pp. 113–126.
  • L. Von Bertalanffy, Problems of organic growth, Nature 163 (1949), pp. 156–158.
  • E. Yada, S. Wada, S. Yoshida, and T. Sasada, Use of Patient-Derived Xenograft Mouse Models in Cancer Research and Treatment, 2017.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.